VeRUS: verification of reference intervals based on the uncertainty of sampling Article Swipe
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1515/cclm-2025-0728
Objectives Laboratories are required to routinely verify reported reference intervals (RIs), but common verification methods like the CLSI-EP28-A3c binomial test are often impractical due to sample collection requirements. Indirect verification methods like equivalence limits (ELs) use routine data from patient care but lack systematic evaluation. This study aimed to develop and evaluate a novel indirect verification method: verification of reference intervals based on the uncertainty of sampling (VeRUS). Methods VeRUS compares the to-be-verified candidate RI to an RI estimated from local routine data. Acceptable differences are based on the sampling uncertainty intrinsic to the nonparametric method for establishing RIs with n=120 samples. The three verification methods were systematically compared with simulated test sets resembling 10 differently distributed biomarkers and a wide range of plausible candidate RIs. Results The binomial test is inherently unable to reject too wide RIs; e.g. the 99.8 %-interval, for which ELs and VeRUS showed high rejection rates (mean 89.2 %, SD 31.5 % and mean 95.8 %, SD 2.3 %, respectively). Moreover, the binomial test incorrectly accepts 29.3 % of “too narrow” 80%-intervals, whereas the false acceptance rates of ELs and VeRUS were lower (mean 21.7 %, SD 40.9 % and mean 7.2 %, SD 4.7 %, respectively). Overall, both indirect verification methods demonstrated increased statistical power, while ELs were least consistent among different biomarker distributions. Conclusions Its robust performance without the need for sample collection makes VeRUS an attractive tool for RI verification. By enabling routine verification of previously practically unverifiable RIs (e.g., in pediatrics), VeRUS may enhance clinical decision-making and improve patient care.
Related Topics
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1515/cclm-2025-0728
- https://www.degruyterbrill.com/document/doi/10.1515/cclm-2025-0728/pdf
- OA Status
- hybrid
- References
- 19
- OpenAlex ID
- https://openalex.org/W4416140691
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4416140691Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1515/cclm-2025-0728Digital Object Identifier
- Title
-
VeRUS: verification of reference intervals based on the uncertainty of samplingWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-11-10Full publication date if available
- Authors
-
Michael D. Beck, Florian Dufey, Christopher M. Rank, Manfred RauhList of authors in order
- Landing page
-
https://doi.org/10.1515/cclm-2025-0728Publisher landing page
- PDF URL
-
https://www.degruyterbrill.com/document/doi/10.1515/cclm-2025-0728/pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
hybridOpen access status per OpenAlex
- OA URL
-
https://www.degruyterbrill.com/document/doi/10.1515/cclm-2025-0728/pdfDirect OA link when available
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
19Number of works referenced by this work
Full payload
| id | https://openalex.org/W4416140691 |
|---|---|
| doi | https://doi.org/10.1515/cclm-2025-0728 |
| ids.doi | https://doi.org/10.1515/cclm-2025-0728 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/41213183 |
| ids.openalex | https://openalex.org/W4416140691 |
| fwci | |
| type | article |
| title | VeRUS: verification of reference intervals based on the uncertainty of sampling |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| language | en |
| locations[0].id | doi:10.1515/cclm-2025-0728 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S124948411 |
| locations[0].source.issn | 1434-6621, 1437-4331 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 1434-6621 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Clinical Chemistry and Laboratory Medicine (CCLM) |
| locations[0].source.host_organization | https://openalex.org/P4310313990 |
| locations[0].source.host_organization_name | De Gruyter |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310313990 |
| locations[0].source.host_organization_lineage_names | De Gruyter |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://www.degruyterbrill.com/document/doi/10.1515/cclm-2025-0728/pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Clinical Chemistry and Laboratory Medicine (CCLM) |
| locations[0].landing_page_url | https://doi.org/10.1515/cclm-2025-0728 |
| locations[1].id | pmid:41213183 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Clinical chemistry and laboratory medicine |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/41213183 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5074298889 |
| authorships[0].author.orcid | https://orcid.org/0009-0008-7678-4581 |
| authorships[0].author.display_name | Michael D. Beck |
| authorships[0].countries | DE |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210094361 |
| authorships[0].affiliations[0].raw_affiliation_string | 111618 Roche Diagnostics GmbH , Penzberg, Germany. |
| authorships[0].affiliations[1].institution_ids | https://openalex.org/I4210088053 |
| authorships[0].affiliations[1].raw_affiliation_string | Department of Pediatrics and Adolescent Medicine, Universitätsklinikum Erlangen, Erlangen, Germany. |
| authorships[0].affiliations[2].institution_ids | https://openalex.org/I181369854 |
| authorships[0].affiliations[2].raw_affiliation_string | Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany. |
| authorships[0].institutions[0].id | https://openalex.org/I181369854 |
| authorships[0].institutions[0].ror | https://ror.org/00f7hpc57 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I181369854 |
| authorships[0].institutions[0].country_code | DE |
| authorships[0].institutions[0].display_name | Friedrich-Alexander-Universität Erlangen-Nürnberg |
| authorships[0].institutions[1].id | https://openalex.org/I4210094361 |
| authorships[0].institutions[1].ror | https://ror.org/00sh68184 |
| authorships[0].institutions[1].type | company |
| authorships[0].institutions[1].lineage | https://openalex.org/I118019719, https://openalex.org/I4210094361 |
| authorships[0].institutions[1].country_code | DE |
| authorships[0].institutions[1].display_name | Roche Pharma AG (Germany) |
| authorships[0].institutions[2].id | https://openalex.org/I4210088053 |
| authorships[0].institutions[2].ror | https://ror.org/0030f2a11 |
| authorships[0].institutions[2].type | healthcare |
| authorships[0].institutions[2].lineage | https://openalex.org/I4210088053 |
| authorships[0].institutions[2].country_code | DE |
| authorships[0].institutions[2].display_name | Universitätsklinikum Erlangen |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Matthias Beck |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | 111618 Roche Diagnostics GmbH , Penzberg, Germany., Department of Pediatrics and Adolescent Medicine, Universitätsklinikum Erlangen, Erlangen, Germany., Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany. |
| authorships[1].author.id | https://openalex.org/A5034817813 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-6467-8556 |
| authorships[1].author.display_name | Florian Dufey |
| authorships[1].countries | DE |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210094361 |
| authorships[1].affiliations[0].raw_affiliation_string | 111618 Roche Diagnostics GmbH , Penzberg, Germany. |
| authorships[1].institutions[0].id | https://openalex.org/I4210094361 |
| authorships[1].institutions[0].ror | https://ror.org/00sh68184 |
| authorships[1].institutions[0].type | company |
| authorships[1].institutions[0].lineage | https://openalex.org/I118019719, https://openalex.org/I4210094361 |
| authorships[1].institutions[0].country_code | DE |
| authorships[1].institutions[0].display_name | Roche Pharma AG (Germany) |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Florian Dufey |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | 111618 Roche Diagnostics GmbH , Penzberg, Germany. |
| authorships[2].author.id | https://openalex.org/A5112309066 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Christopher M. Rank |
| authorships[2].countries | DE |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210094361 |
| authorships[2].affiliations[0].raw_affiliation_string | 111618 Roche Diagnostics GmbH , Penzberg, Germany. |
| authorships[2].institutions[0].id | https://openalex.org/I4210094361 |
| authorships[2].institutions[0].ror | https://ror.org/00sh68184 |
| authorships[2].institutions[0].type | company |
| authorships[2].institutions[0].lineage | https://openalex.org/I118019719, https://openalex.org/I4210094361 |
| authorships[2].institutions[0].country_code | DE |
| authorships[2].institutions[0].display_name | Roche Pharma AG (Germany) |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Christopher M Rank |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | 111618 Roche Diagnostics GmbH , Penzberg, Germany. |
| authorships[3].author.id | https://openalex.org/A5015914687 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-4852-7157 |
| authorships[3].author.display_name | Manfred Rauh |
| authorships[3].countries | DE |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210088053 |
| authorships[3].affiliations[0].raw_affiliation_string | Department of Pediatrics and Adolescent Medicine, Universitätsklinikum Erlangen, Erlangen, Germany. |
| authorships[3].institutions[0].id | https://openalex.org/I4210088053 |
| authorships[3].institutions[0].ror | https://ror.org/0030f2a11 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210088053 |
| authorships[3].institutions[0].country_code | DE |
| authorships[3].institutions[0].display_name | Universitätsklinikum Erlangen |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Manfred Rauh |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Department of Pediatrics and Adolescent Medicine, Universitätsklinikum Erlangen, Erlangen, Germany. |
| has_content.pdf | True |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.degruyterbrill.com/document/doi/10.1515/cclm-2025-0728/pdf |
| open_access.oa_status | hybrid |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-11-10T00:00:00 |
| display_name | VeRUS: verification of reference intervals based on the uncertainty of sampling |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-28T06:11:11.548884 |
| primary_topic | |
| cited_by_count | 0 |
| locations_count | 2 |
| best_oa_location.id | doi:10.1515/cclm-2025-0728 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S124948411 |
| best_oa_location.source.issn | 1434-6621, 1437-4331 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 1434-6621 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Clinical Chemistry and Laboratory Medicine (CCLM) |
| best_oa_location.source.host_organization | https://openalex.org/P4310313990 |
| best_oa_location.source.host_organization_name | De Gruyter |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310313990 |
| best_oa_location.source.host_organization_lineage_names | De Gruyter |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://www.degruyterbrill.com/document/doi/10.1515/cclm-2025-0728/pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Clinical Chemistry and Laboratory Medicine (CCLM) |
| best_oa_location.landing_page_url | https://doi.org/10.1515/cclm-2025-0728 |
| primary_location.id | doi:10.1515/cclm-2025-0728 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S124948411 |
| primary_location.source.issn | 1434-6621, 1437-4331 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 1434-6621 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Clinical Chemistry and Laboratory Medicine (CCLM) |
| primary_location.source.host_organization | https://openalex.org/P4310313990 |
| primary_location.source.host_organization_name | De Gruyter |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310313990 |
| primary_location.source.host_organization_lineage_names | De Gruyter |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://www.degruyterbrill.com/document/doi/10.1515/cclm-2025-0728/pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Clinical Chemistry and Laboratory Medicine (CCLM) |
| primary_location.landing_page_url | https://doi.org/10.1515/cclm-2025-0728 |
| publication_date | 2025-11-10 |
| publication_year | 2025 |
| referenced_works | https://openalex.org/W4363646321, https://openalex.org/W1866454189, https://openalex.org/W2004624314, https://openalex.org/W2802841668, https://openalex.org/W2119063824, https://openalex.org/W2059890270, https://openalex.org/W4404631754, https://openalex.org/W3153544820, https://openalex.org/W4313703429, https://openalex.org/W4383710100, https://openalex.org/W3189962299, https://openalex.org/W2339469049, https://openalex.org/W4401076709, https://openalex.org/W4306897063, https://openalex.org/W3189608757, https://openalex.org/W4390691417, https://openalex.org/W2584480920, https://openalex.org/W4321498574, https://openalex.org/W2408017125 |
| referenced_works_count | 19 |
| abstract_inverted_index.% | 157, 173, 194 |
| abstract_inverted_index.a | 53, 120 |
| abstract_inverted_index.%, | 154, 161, 164, 191, 198, 201 |
| abstract_inverted_index.10 | 115 |
| abstract_inverted_index.By | 239 |
| abstract_inverted_index.RI | 75, 78, 237 |
| abstract_inverted_index.SD | 155, 162, 192, 199 |
| abstract_inverted_index.an | 77, 233 |
| abstract_inverted_index.in | 249 |
| abstract_inverted_index.is | 131 |
| abstract_inverted_index.of | 59, 66, 123, 174, 183, 243 |
| abstract_inverted_index.on | 63, 88 |
| abstract_inverted_index.to | 5, 25, 49, 76, 93, 134 |
| abstract_inverted_index.2.3 | 163 |
| abstract_inverted_index.4.7 | 200 |
| abstract_inverted_index.7.2 | 197 |
| abstract_inverted_index.ELs | 145, 184, 213 |
| abstract_inverted_index.Its | 222 |
| abstract_inverted_index.RIs | 99, 247 |
| abstract_inverted_index.The | 103, 128 |
| abstract_inverted_index.and | 51, 119, 146, 158, 185, 195, 256 |
| abstract_inverted_index.are | 3, 21, 86 |
| abstract_inverted_index.but | 12, 42 |
| abstract_inverted_index.due | 24 |
| abstract_inverted_index.for | 97, 143, 228, 236 |
| abstract_inverted_index.may | 252 |
| abstract_inverted_index.the | 17, 64, 72, 89, 94, 140, 167, 179, 226 |
| abstract_inverted_index.too | 136 |
| abstract_inverted_index.use | 36 |
| abstract_inverted_index.21.7 | 190 |
| abstract_inverted_index.29.3 | 172 |
| abstract_inverted_index.31.5 | 156 |
| abstract_inverted_index.40.9 | 193 |
| abstract_inverted_index.89.2 | 153 |
| abstract_inverted_index.95.8 | 160 |
| abstract_inverted_index.99.8 | 141 |
| abstract_inverted_index.RIs. | 126 |
| abstract_inverted_index.RIs; | 138 |
| abstract_inverted_index.This | 46 |
| abstract_inverted_index.both | 204 |
| abstract_inverted_index.care | 41 |
| abstract_inverted_index.data | 38 |
| abstract_inverted_index.e.g. | 139 |
| abstract_inverted_index.from | 39, 80 |
| abstract_inverted_index.high | 149 |
| abstract_inverted_index.lack | 43 |
| abstract_inverted_index.like | 16, 32 |
| abstract_inverted_index.mean | 159, 196 |
| abstract_inverted_index.need | 227 |
| abstract_inverted_index.sets | 113 |
| abstract_inverted_index.test | 20, 112, 130, 169 |
| abstract_inverted_index.tool | 235 |
| abstract_inverted_index.were | 107, 187, 214 |
| abstract_inverted_index.wide | 121, 137 |
| abstract_inverted_index.with | 100, 110 |
| abstract_inverted_index.(ELs) | 35 |
| abstract_inverted_index.(mean | 152, 189 |
| abstract_inverted_index.VeRUS | 70, 147, 186, 232, 251 |
| abstract_inverted_index.aimed | 48 |
| abstract_inverted_index.among | 217 |
| abstract_inverted_index.based | 62, 87 |
| abstract_inverted_index.care. | 259 |
| abstract_inverted_index.data. | 83 |
| abstract_inverted_index.false | 180 |
| abstract_inverted_index.least | 215 |
| abstract_inverted_index.local | 81 |
| abstract_inverted_index.lower | 188 |
| abstract_inverted_index.makes | 231 |
| abstract_inverted_index.n=120 | 101 |
| abstract_inverted_index.novel | 54 |
| abstract_inverted_index.often | 22 |
| abstract_inverted_index.range | 122 |
| abstract_inverted_index.rates | 151, 182 |
| abstract_inverted_index.study | 47 |
| abstract_inverted_index.three | 104 |
| abstract_inverted_index.which | 144 |
| abstract_inverted_index.while | 212 |
| abstract_inverted_index.(RIs), | 11 |
| abstract_inverted_index.(e.g., | 248 |
| abstract_inverted_index.common | 13 |
| abstract_inverted_index.limits | 34 |
| abstract_inverted_index.method | 96 |
| abstract_inverted_index.power, | 211 |
| abstract_inverted_index.reject | 135 |
| abstract_inverted_index.robust | 223 |
| abstract_inverted_index.sample | 26, 229 |
| abstract_inverted_index.showed | 148 |
| abstract_inverted_index.unable | 133 |
| abstract_inverted_index.verify | 7 |
| abstract_inverted_index.“too | 175 |
| abstract_inverted_index.Methods | 69 |
| abstract_inverted_index.Results | 127 |
| abstract_inverted_index.accepts | 171 |
| abstract_inverted_index.develop | 50 |
| abstract_inverted_index.enhance | 253 |
| abstract_inverted_index.improve | 257 |
| abstract_inverted_index.method: | 57 |
| abstract_inverted_index.methods | 15, 31, 106, 207 |
| abstract_inverted_index.patient | 40, 258 |
| abstract_inverted_index.routine | 37, 82, 241 |
| abstract_inverted_index.whereas | 178 |
| abstract_inverted_index.without | 225 |
| abstract_inverted_index.(VeRUS). | 68 |
| abstract_inverted_index.Abstract | 0 |
| abstract_inverted_index.Indirect | 29 |
| abstract_inverted_index.Overall, | 203 |
| abstract_inverted_index.binomial | 19, 129, 168 |
| abstract_inverted_index.clinical | 254 |
| abstract_inverted_index.compared | 109 |
| abstract_inverted_index.compares | 71 |
| abstract_inverted_index.enabling | 240 |
| abstract_inverted_index.evaluate | 52 |
| abstract_inverted_index.indirect | 55, 205 |
| abstract_inverted_index.reported | 8 |
| abstract_inverted_index.required | 4 |
| abstract_inverted_index.samples. | 102 |
| abstract_inverted_index.sampling | 67, 90 |
| abstract_inverted_index.Moreover, | 166 |
| abstract_inverted_index.biomarker | 219 |
| abstract_inverted_index.candidate | 74, 125 |
| abstract_inverted_index.different | 218 |
| abstract_inverted_index.estimated | 79 |
| abstract_inverted_index.increased | 209 |
| abstract_inverted_index.intervals | 10, 61 |
| abstract_inverted_index.intrinsic | 92 |
| abstract_inverted_index.narrow” | 176 |
| abstract_inverted_index.plausible | 124 |
| abstract_inverted_index.reference | 9, 60 |
| abstract_inverted_index.rejection | 150 |
| abstract_inverted_index.routinely | 6 |
| abstract_inverted_index.simulated | 111 |
| abstract_inverted_index.Acceptable | 84 |
| abstract_inverted_index.Objectives | 1 |
| abstract_inverted_index.acceptance | 181 |
| abstract_inverted_index.attractive | 234 |
| abstract_inverted_index.biomarkers | 118 |
| abstract_inverted_index.collection | 27, 230 |
| abstract_inverted_index.consistent | 216 |
| abstract_inverted_index.inherently | 132 |
| abstract_inverted_index.previously | 244 |
| abstract_inverted_index.resembling | 114 |
| abstract_inverted_index.systematic | 44 |
| abstract_inverted_index.%-interval, | 142 |
| abstract_inverted_index.Conclusions | 221 |
| abstract_inverted_index.differences | 85 |
| abstract_inverted_index.differently | 116 |
| abstract_inverted_index.distributed | 117 |
| abstract_inverted_index.equivalence | 33 |
| abstract_inverted_index.evaluation. | 45 |
| abstract_inverted_index.impractical | 23 |
| abstract_inverted_index.incorrectly | 170 |
| abstract_inverted_index.performance | 224 |
| abstract_inverted_index.practically | 245 |
| abstract_inverted_index.statistical | 210 |
| abstract_inverted_index.uncertainty | 65, 91 |
| abstract_inverted_index.Laboratories | 2 |
| abstract_inverted_index.demonstrated | 208 |
| abstract_inverted_index.establishing | 98 |
| abstract_inverted_index.pediatrics), | 250 |
| abstract_inverted_index.unverifiable | 246 |
| abstract_inverted_index.verification | 14, 30, 56, 58, 105, 206, 242 |
| abstract_inverted_index.CLSI-EP28-A3c | 18 |
| abstract_inverted_index.nonparametric | 95 |
| abstract_inverted_index.requirements. | 28 |
| abstract_inverted_index.verification. | 238 |
| abstract_inverted_index.80%-intervals, | 177 |
| abstract_inverted_index.distributions. | 220 |
| abstract_inverted_index.respectively). | 165, 202 |
| abstract_inverted_index.systematically | 108 |
| abstract_inverted_index.to-be-verified | 73 |
| abstract_inverted_index.decision-making | 255 |
| cited_by_percentile_year | |
| countries_distinct_count | 1 |
| institutions_distinct_count | 4 |
| citation_normalized_percentile |